1. C.D. Kaur, K.K Mishra, A. Sahu, R. Panik, P. Kashyap, S.P. Mishra, A. Kumar, Theranostics: New Era in Nuclear Medicine and Radiopharmaceuticals, Medical Isotopes, Syed Ali Raza Naqvi and Muhammad Babar Imrani, IntechOpen. https://doi.org/10.5772/intechopen.91868. Available from: https://www.intechopen.com/books/medical-isotopes/theranostics-new-era-in-nuclear-medicine-and-radiopharmaceuticals
2. G. Sgouros, L. Bodei, M. McDevitt, J. Nedrow, Author Correction: Radiopharmaceutical therapy in cancer: clinical advances and challenges. Nat. Rev. Drug Discov. 19(11), 819–819 (2020). https://doi.org/10.1038/s41573-020-0085-5
3. International Atomic Energy Agency, Trends in Radiopharmaceuticals (ISTR-2019), Proceedings of an International Symposium, Vienna, Austria, 28 October–1 November 2019
4. ICRP, Release of patients after therapy with unsealed radionuclides. ICRP Publication 94. (ICRP, 2004)
5. European Commission, Radiation Protection Following Iodine-131 Therapy (Exposures Due to Out-Patients or Discharged In-Patients), Radiation Protection 97 (European Commission, Luxembourg, 1998)